baber/WOPTO huggingface dataset:
Patent EP-2246669-A2 (EP)
Inventor: HELD SIEGFRIED
IPC: G01D5/241
Filed: 2010-03-26
Abstract: A capacitive rotation sensor for detecting the position of an object moving relative to a stationary object, comprises a shaft (3) rotatably supported in a housing flange (1); a stator (8) situated opposite to it is assigned, where at least the rotor, the stator and an evaluation circuit are enclosed by an electrically conductive cap; and a non-rotation-symmetrical rotor disc (6) which, in turn, is fixed on a rotor support (5), where the rotor support is fastened highly precisely on the outer periphery of the shaft so as to be integral in rotation with it. A capacitive rotation sensor for detecting the position of an object moving relative to a stationary object, comprises a shaft (3) rotatably supported in a housing flange (1), where the shaft is connected integral in rotation with it to a rotor to which, separated by an air gap; a stator (8) situated opposite to it is assigned, where at least the rotor, the stator and an evaluation circuit are enclosed by an electrically conductive cap, where a stator surface is arranged on the underside of a circuit board and that the stator surface has assigned to it, situated opposite to it and separated by the air gap; and a non-rotation-symmetrical rotor disc (6) which, in turn, is fixed on a rotor support (5), where the rotor support is fastened highly precisely on the outer periphery of the shaft so as to be integral in rotation with it.
Patent EP-2266960-A2 (EP)
Inventor: HOGENKAMP DERK J
IPC: A61P23/02
Filed: 2000-03-24
Abstract: Aryl Substituted Pyrazoles, Imidazoles, Oxazoles, Thiazoles and Pyrroles, and the Use Thereof
       
     This invention relates to compounds having formula (I) or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Het and R 5 -R 13  are set in the specification. The invention also is directed to the use of compounds of formula (I) for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
Patent EP-2266616-A2 (EP)
Inventor: TUERECI OEZLEM
IPC: A61K39/00
Filed: 2004-09-23
Abstract: Pharmaceutical composition (A) comprises an agent (B) that inhibits the activity or expression of a specific tumor-associated antigen (TAg) that is encoded by one of the following nucleic acids (NA): (a) any of 75 sequences (reproduced) or their fragments or derivatives; (b) a sequence that hybridizes to (a) under stringent conditions; (c) degenerate variants of (a) or (b); or (d) a complement of (a)-(c). Independent claims are also included for the following: (1) similar composition (A1) containing an agent (B1) with tumor-inhibiting action selective for cells showing (abnormal) expression of TAg; (2) similar composition (A2) containing an agent (B2) that selectively increases the amount of complex formed between an HLA molecule and TAg (or part of it); (3) pharmaceutical composition (A3) comprising TAg, NA, antibodies directed against TAg (or their fragments), antisense nucleic acid that hybridizes to NA, host cells that express TAg (or fragment), or isolated complexes of TAg with an HLA molecule; (4) method for diagnosing a disease associated with (abnormal) expression of TAg; (5) method for determining regression, progression and onset of a disease associated with (abnormal) expression of TAg; (6) several methods for treating diseases associated with (abnormal) expression of TAg; (7) method for treating, diagnosing and monitoring diseases associated with (abnormal) expression of TAg by administering an antibody, optionally linked to a therapeutic or diagnostic agent, that binds to TAg; (8) NA, or any nucleic acid that encodes the same proteins, as new compounds; (9) recombinant DNA or RNA containing the nucleic acid of (8); (10) host cells that contain the nucleic acids of (8) or (9); (11) proteins and polypeptides (P) encoded by the nucleic acids of (8), also their immunogenic fragments that bind to a human HLA receptor or human antibody; (12) agent (X) that binds specifically to (P), or part of it; (13) antibody (Ab) that binds selectively to a complex of (P), or its fragment, and an MHC molecule; (14) conjugate between (X) or Ab and a therapeutic or diagnostic agent; (15) kit for detecting (abnormal) expression of TAg; (16) recombinant DNA containing a promoter region derived from any of the 75 specified sequences; (17) pharmaceutical composition containing an agent that inhibits expression or activity of a tumor-associated antigen (TAg1) having any of 75 amino acid sequences reproduced; and (18) antibody (Ab1) that binds to an extracellular domain of TAg1. ACTIVITY : Cytostatic. No details of tests for cytostatic activity are given. MECHANISM OF ACTION : Inhibiting expression or activity of specific antigens; Antisense therapy; RNA Interference.
Patent EP-2259581-A2 (EP)
Inventor: CHO CHANG-HYUNG
IPC: H04N5/76
Filed: 2001-12-04
Abstract: A method and apparatus for extracting a category item from an audio/video (A/V) signal to be recorded on a storage medium, storing the extracted category item, and searching for the AN signal using the category item are provided. The method of recording an A/V signal includes the steps of seizing the category of the A/V signal and selecting a category item for the A/V signal, storing category information about the A/V signal, the category information including the category item, and recording the A/V signal to a storage medium. Accordingly, an A/V signal stored in a storage medium can be searched for by a category so that the A/V signal can be easily searched for. Since the compression ratio of each A/V signal is controlled depending on its category when the A/S signal is recorded to a storage medium, the storage capacity of the storage medium can be efficiently managed.
Patent EP-2295586-A2 (EP)
Inventor: MACH JENNIFER
IPC: A01H5/00
Filed: 2003-06-27
Abstract: The present invention provides for the nucleic acid sequences of plant centromeres. This will permit construction of stably inherited recombinant DNA constructs and minichromosomes which can serve as vectors for the construction of transgenic plant and animal cells.
Patent EP-2354551-A2 (EP)
Inventor: GRIESE KLAUS
IPC: F04C15/00
Filed: 2010-11-26
Abstract: The machine (1) has a housing (2) in which two helical gear wheels (10, 12) and axial bearing bodies (26, 28) are accommodated. Shafts (8, 16) are accommodated in the bearing bodies, where axial force components of force, resulting from hydraulic and mechanical forces during operation of the machine, act on the gear wheels. Compensation bodies (60, 62) are arranged coaxial to the shafts for pressing the shafts with axial compensation forces (50, 51). The compensation bodies and the respective shafts are connected with each other in a torque-proof manner.
Patent EP-2250987-A2 (EP)
Inventor: BOBEY JOHN A
IPC: A61G7/00
Filed: 2005-05-02
Abstract: This disclosure describes certain exemplary embodiments of a patient support (10) having a plurality of vertically-oriented on substantially can-shaped inflatable bladders (50). In one embodiment, the patient support includes a plurality of pressure sensors (136) positioned underneath the bladders. In another embodiment, the patient support includes a support layer (20) positioned above the vertical bladders. In still another embodiment, the patient support includes one or more filler portions (80, 84, 86, 90) that are selectable so that the patient support may conform to bed frames, having different deck configurations. 
     In certain embodiments, a patient support having real time pressure control is provided. The patient support includes a plurality of sensors heated beneath a bladder including a plurality of upright cylindrical elements. The pressure within the bladder is controlled based on the pressure or force sensed by the plurality of sensors. 
     In certain embodiments, a lack of patient movement monitor and method is provided. The monitor and method patient support includes a plurality of sensors located beneath a patient support to determine movement of a patient. Art alarm is activated when patient movement over time is determined to be lacking. 
     The present invention also includes a pressure relief patient support (1010) for use in combination with a bed frame. The pressure relief support surface includes a plurality of layers of a three-dimensional fiber material (1302) positioned above a plurality of vertical air cells (50).
Patent EP-2363691-A2 (EP)
Inventor: IHARA KOJI
IPC: G08G1/0969
Filed: 2002-09-03
Abstract: There is provided a map display device for simultaneously displaying two screens of maps on a common display unit, the device comprising a resolution conversion unit for converting the resolution of the map data, wherein the display unit has a predetermined display area for displaying a map based on the map data with its resolution converted, wherein on a primary screen displayed in the entire display area of the display unit, a secondary screen having different resolution from that of the primary screen is displayed.
Patent EP-2296083-A2 (EP)
Inventor: NISHIJIMA AKIO
IPC: G06F3/044
Filed: 2010-09-08
Abstract: An electrostatic capacitive touch sensor (1) is structured to switch the detection mode between a first detection mode in which the plural detection electrodes (2 1  to 2 4 ) are connected in parallel to serve as a unit of the detection electrodes for detecting an approaching object and a second detection mode in which the parallel connections of the plural detection electrodes (2 1  to 2 4 ) are released to individually detect the object approaching the respective detection electrodes (2 1  to 2 4 ).
Patent EP-2261344-A2 (EP)
Inventor: FRASER CLAIRE
IPC: A61P31/04
Filed: 1999-04-30
Abstract: The invention provides proteins from Neisseria mcningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.
Patent EP-2298301-A2 (EP)
Inventor: KLAUS STEPHEN J
IPC: G01N33/74
Filed: 2002-12-06
Abstract: The present invention relates to compounds for use in methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin  in vitro  and  in vivo . Compounds for use in methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included.
Patent EP-2363403-A2 (EP)
Inventor: DALLA-FAVERA RICCARDO
IPC: C12Q1/02
Filed: 2000-11-28
Abstract: This invention provides an isolated nucleic acid molecule which encodes immunoglobulin receptor, Immunoglobulin superfamily Receptor Translocation Associated, IRTA, protein. Provided too, are the IRTA proteins encoded by the isolated nucleic acid molecules, IRTA1, IRTA2, IRTA3, IRTA4 or IRTA5 proteins, having the amino acid sequences set forth in any of  Figures 18A ,  18B-1-18B-3 ,  18C-1-18C-2 ,  18D-1-18D-2  or  18E-1-18E-2 . Oligonucleotides of the isolated nucleic acid molecules are provided, Antibodies directed to an epitope of a purified IRTA1, IRTA2, IRTA3, IRTA4 or 1RTA5 proteins are also provided, as are pharmaceutical compositions comprising such antibodies or oligonucleotides. Methods for detecting a B cell malignancy in a sample from a subject; diagnosing B cell malignancy in a sample from a subject; detecting human IRTA protein in a sample; and treating a subject having a B cell cancer are also provided.
Patent EP-2334065-A2 (EP)
Inventor: OZKALAYCI BURAK
IPC: H04N5/14
Filed: 2010-12-01
Abstract: Motion vector field retiming is the most common method for motion compensated interpolation especially in frame rate up - conversion applications. However, halo problems occur at occlusion regions on object - motion boundaries because of wrong motion estimation. Thus, a reliable re-timed motion vector field is needed to acquire a motion vector field at the temporal location of the frame to be interpolated. In present invention a novel motion vector field retiming method is described. According to said method, FG (3) - BG (4) discrimination metric is calculated for previous motion vector field (f n ) and next motion vector field (f n+1 ) .  According to calculated discrimination metric, projection of previous motion vector field (f n ) in forward direction (101) and next motion vector field (f n+1 ) in backward direction (102) is done. Said projected vectors (101, 102) compose a motion vector field which is interpolated between previous frame (f n ) and next frame (f n+1 ) .  By using FG (3) - BG (4) discrimination metric with projection of motion vector fields in previous frame (f n ) and next frame (f n+1 ), halo problems are overcome.
Patent EP-2325414-A2 (EP)
Inventor: GYURICA GABOR
IPC: E04F21/08
Filed: 2010-02-24
Abstract: The apparatus comprises a sheet metal-covered rectangular cabinet on a frame structure made of angle steel. Three slot rails (2) are mounted on a work table (1), on which two parallel and adjustable positioning bars (3) are laid and attached with screws. A gear drive is installed on a sliding bar below the plane of the work table, where the gear drive is actuated by a sliding jaw.
Patent EP-2440086-A2 (EP)
Title: Procédé de raidissement d'un élément décoratif comprenant une pluralité d'éléments concaténés
Inventor: PERIN GIORDANA
IPC: A44C27/00
Filed: 2010-04-15
Abstract: L'invention porte sur un procédé (1) de raidissement d'un élément décoratif (100) comprenant une pluralité d'éléments concaténés (101), incluant les étapes de préparation d'un modèle (200) comportant une cavité (201) légèrement abaissée par rapport à la surface supérieure (202) du modèle lui-même, d'introduction de l'élément décoratif (100) dans la cavité (201), d'interposition d'un moyen de brasure entre l'élément décoratif (100) et une paroi (203, 204) de la cavité (201), de chauffage du modèle (200) conjointement avec l'élément décoratif (100) jusqu'à la température de fusion de l'élément de brasure, de refroidissement du modèle (200) à la température ambiante et enfin d'extraction de l'élément décoratif (100) du modèle (200).
Patent EP-2451458-A2 (EP)
Title: Compositions pharmaceutiques et formes solides
Inventor: BERGHAUSEN JOERG
IPC: A61K47/10
Filed: 2010-07-05
Abstract: La présente invention concerne des compositions pharmaceutiques de (3-trifluorométhyl-phényl)-amide d'acide 6-(6-hydroxyméthyl-pyrimidin-4-yloxy)-naphthalène-1-carboxylique, l'utilisation de (3-trifluorométhyl-phényl)-amide d'acide 6-(6-hydroxyméthyl-pyrimidin-4-yloxy)-naphthalène-1-carboxylique et des compositions de (3-trifluorométhyl-phényl)-amide d'acide 6-(6-hydroxyméthyl-pyrimidin-4-yloxy)-naphthalène-1-carboxylique dans des applications thérapeutiques, en particulier des indications associées à une mauvaise régulation/surexpression de VEGF, une (néo)vascularisation et une angiogenèse dirigée par VEGF et des procédés de fabrication de ces compositions. L'invention concerne en outre des formes spécifiques de (3-trifluorométhyl-phényl)-amide d'acide 6-(6-hydroxyméthyl-pyrimidin-4-yloxy)-naphthalène-1-carboxylique et la fabrication et l'utilisation de ces formes. La présente invention concerne également un nouveau procédé pour produire du (3-trifluorométhyl-phényl)-amide d'acide 6-(6-hydroxyméthyl-pyrimidin-4-yloxy)-naphthalène-1-carboxylique.
Patent EP-2467437-A2 (EP)
Inventor: FASSAM ROBERT AUGUSTUS
IPC: C09D11/00
Filed: 2010-08-20
Abstract: The present invention provides an inkjet ink comprising at least 30 % by weight of organic solvent based on the total weight of the ink, a radiation curable material, a photoinitiator and optionally a colourant. The invention also provides an apparatus for printing the ink wherein the apparatus comprises at least one printhead, a means for evaporating solvent from the printed ink and a source of actinic radiation. Furthermore, the invention provides a method of inkjet printing comprisingi) inkjet printing the inkjet ink as defined above on to a substrate;ii)evaporating at least a portion of the solvent from the printed ink; and iii)exposing the printed ink to actinic radiation to cure the radiation curable material.
Patent EP-2404408-A2 (EP)
Title: Procédé et appareil permettant de restreindre la divulgation d'informations de réseau au cours d'un service d'accès à distance
Inventor: HAN SE-HEE
IPC: H04L12/28
Filed: 2010-03-03
Abstract: La présente invention concerne un procédé et un appareil permettant de restreindre la divulgation d'informations concernant un dispositif de réseau au cours d'un service d'accès à distance (RA). Selon l'invention, un dispositif virtuel est activé par un dispositif de service RA; un dispositif ou un service, destiné à divulguer les informations à un réseau extérieur, est déterminé parmi les dispositifs découverts par le dispositif de service RA puis enregistré en tant que dispositif ou service intégré au dispositif virtuel; une description de dispositif relative au dispositif virtuel comprenant le dispositif ou service intégré est générée de manière dynamique; une URL (Uniform Resource Locator) du dispositif de service RA, l'URL permettant l'acquisition de la description de dispositif relative au dispositif virtuel, est générée puis ouverte à un dispositif tiers ayant accédé à distance au dispositif de service RA; puis la description de dispositif relative au dispositif virtuel est envoyée dès la réception d'une demande de description de dispositif relative au dispositif virtuel par l'intermédiaire de l'URL.
Patent EP-2462368-A2 (EP)
Title: Clapet proportionnel doté d'un clapet anti-retour intégré
Inventor: HUYNH TAM C
IPC: F16K31/124
Filed: 2010-08-03
Abstract: La présente invention concerne un ensemble clapet qui comprend un corps ayant une première et une seconde partie d'extrémité axiale. La première partie d'extrémité axiale comprend une surface conique capable de venir en prise étanche avec un siège de clapet. La seconde partie d'extrémité axiale définit un orifice de dosage. Le corps définit un passage qui comprend une ouverture dans la première partie d'extrémité axiale et est en communication fluidique avec l'orifice de dosage. Le passage comprend un siège de clapet anti-retour. Un clapet anti-retour est disposé dans le passage. Le clapet anti-retour peut venir en prise étanche avec le siège de clapet anti-retour.
Patent EP-2467909-A2 (EP)
Inventor: ERBERT GOETZ
IPC: H01S5/20
Filed: 2010-08-23
Abstract: The present invention relates to a diode laser and to a laser resonator for a diode laser having improved lateral beam quality without using an external resonator. The present invention in particular relates to a broad area laser having high power output. It is the aim of the present invention to provide a diode laser and a laser resonator for a diode laser, which has high lateral beam quality at high power output, requires little adjustment effort and is inexpensive to produce. The laser resonator according to the invention comprises a gain section (GS), a first planar Bragg reflector (DBR1) and a second planar Bragg reflector (DBR2), wherein the gain section (GS) has a trapezoidal design and the first planar Bragg reflector (DBR1) is arranged on a first base side of the trapezoidal gain section (GS) and the second planar Bragg reflector (DBR2) is arranged on the opposing base side of the trapezoidal gain section (GS), wherein the width (D1) of the first planar Bragg reflector (DBR1) differs from the width (D2) of the second planar Bragg reflector (DBR2).
Patent EP-2476107-A2 (EP)
Title: Verfahren und anordnung zur übertragung von daten für die wartung eines selbstbedienungsterminals
Inventor: BLUME MARCO
IPC: G07F19/00
Filed: 2010-09-09
Abstract: Zur Wartung von Selbstbedienungsterminals (SB-Terminals) müssen Daten über Telekommunikationsverbindungen an eine Datenzentrale übertragen werden. In besonders sensitiven Anwendungsbereichen ist jedoch ein direkter Anschluss von SB-Terminals an externe Netze oder Geräte unerwünscht. Üblicherweise muss dann das Wartungspersonal vor Ort am jeweiligen SB-Terminal die Service- und Diagnosedaten abfragen und diese fernmündlich dem Help-Desk-Personal in der Datenzentrale mitteilen. Um zu erreichen, dass auch ohne direkten Anschluss des jeweiligen SB-Terminals die Wartungs- und Diagnosedaten direkt zwischen dem SB-Terminal und der Datenzentrale übertragen werden können, wird vorgeschlagen, dass die Daten im Nahbereich des Selbstbedienungsterminals (100) über Ausgabe- und Aufnahmevorrichtungen (150, 160, 170; MA, CAM, F) in einer stromlosen und funkfreien Datenübertragungsform übertragen werden. Dies kann z. B. durch Anzeige und Einlesen von Barcodes (BC) erfolgen.
Patent EP-2507706-A2 (EP)
Inventor: YEE BENNET S
IPC: G06F9/445
Filed: 2010-12-02
Abstract: Methods and apparatus for dynamically adding and deleting new code to previously validated application executing in a secured runtime. New code is written to a portion of secured memory not executable by application. New code is validated to ensure it cannot directly call operating system, address memory outside of secured memory, or modify secured memory state. Indirect branch instructions may only target addresses aligned on fixed size boundaries within the secured memory. Validated code is copied to portion of secured memory executable by application in two stage process that ensures partially copied segments cannot be executed. Validated new code can be deleted once all threads reach safe execution point, provided code was previously inserted as unit or contains no internal targets that can be called by code not also being deleted.
Patent EP-2455084-A2 (EP)
Inventor: KIM HYE-JIN
IPC: A23L1/30
Filed: 2010-07-13
Abstract: The present invention related to an antihypertensive composition containing a fraction enriched with ginsenosides of ginseng. The composition according to the present invention increases the production of nitric oxide through the activation of nitric oxide synthase, and thus exhibits superior antihypertensive effects through the vasodilatory activity. Consequently, the composition of the present invention can be used as a composition for preparing functional health foods for preventing and treating hypertension and various cardiovascular diseases caused by complications of hypertension.
Patent EP-2476180-A2 (EP)
Title: Procédé et appareil permettant de charger une batterie
Inventor: LIN MICHAEL
IPC: H02J7/00
Filed: 2010-09-10
Abstract: La présente invention a trait à un procédé et à un appareil permettant d'identifier différents types de sources d'énergie utilisées pour charger une batterie en recevant de l'énergie provenant au moins d'un des différents types de sources d'énergie à des bornes d'entrée, en identifiant le type de source d'énergie et en sélectionnant un mode permettant de charger la batterie en fonction du type de source d'énergie identifiée. La présente invention a également trait à un procédé et à un appareil de protection contre certaines sources d'énergie utilisées pour charger une batterie.
Patent EP-2375182-A2 (EP)
Inventor: BRUGMANN JOHANNES DR
IPC: F24F13/24
Filed: 2011-03-10
Abstract: The house wall duct (100) has splitter attenuators arranged substantially parallel to an air passage direction of the wall bushing. Two sections (101,102) are designed such that the former section and the latter section are pushed telescopically into one another. A damping material (140) is arranged between the two sections, where a protective grid (110) is arranged at an exterior wall.